CCC
ABBV icon

Compass Capital Corp’s AbbVie ABBV Stock Holding History

Compass Capital Corp’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$303K Buy
1,214
+1
+0.1% +$215 0.1% 166
2026
Q1 		$246K Buy
1,213
+1
+0.1% +$222 0.09% 184
2025
Q4 		$271K Sell
1,212
-17
-1% -$3.87K 0.1% 162
2025
Q3 		$269K Buy
1,229
+70
+6% +$14.3K 0.12% 137
2025
Q2 		$221K Sell
1,159
-4
-0.3% -$743 0.1% 165
2025
Q1 		$243K Sell
1,163
-399
-26% -$77.6K 0.13% 155
2024
Q4 		$268K Buy
+1,562
New +$287K 0.1% 172

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Compass Capital Corp's ABBV Position: Q2 2026 in Review

Compass Capital Corp increased its AbbVie (ABBV) stake by 0.08% in Q2 2026, buying an estimated $215 and bringing the position to 1,214 shares worth $303K. The position accounts for 0.1% of the portfolio, ranked #166.

Compass Capital Corp first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Compass Capital Corp held 1,214 shares of AbbVie worth $303K as of Q2 2026.
  • Compass Capital Corp bought 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.1% of Compass Capital Corp's portfolio in Q2 2026, its #166 holding.
  • Compass Capital Corp first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Compass Capital Corp's 13F filing for Q2 2026, filed 13 Aug 2026.